HRT and Cancer Research
Researchers at The University of Texas M.D. Anderson Cancer Center report fewer incidences of breast cancer in 2003 and speculate this may be due to millions of women ceasing the use of hormone replacement therapy in 2002.
The largest decline was found among women in the 50-69 age group. There was a 12% drop in women of that age group being diagnosed with estrogen receptor positive breast cancer.
Researchers cautiously suggest that the decline may be due to the fact that half of the 30% of women over 50 who were taking HRT stopped when it was announced that it contributed to the incidence of breast cancer and tumor growth.
